What Happened

21Shares just dropped Amendment No. 5 to its S-1 filing for the spot XRP ETF on December 8, 2025. This one’s a beast—cuts the sponsor fee to a razor-thin 0.21% after a six-month waiver period, positioning TOXR as one of the cheapest XRP plays out there. Filed with the SEC same day, it’s the final polish before effectiveness.

Here’s the deal: They’ve checked the ‘continuous offering’ box, confirmed custody with Anchorage Digital and BitGo, and nailed down creation/redemption mechanics. No more delay clauses in some spots, but the SEC still needs to declare it effective. CT’s buzzing—posts on X calling it the ‘final push’ before approval.

Trading under ticker TOXR on Cboe BZX once greenlit. We’ve seen this playbook with SOL and ETH ETFs. Remember when 21Shares slashed ARKB fees to snag inflows? Same energy here.

The Background

XRP’s ETF saga kicked off hard after the 2023 court win against the SEC—Ripple not a security for retail sales. Fast forward to 2025: Canada’s already got spot XRP ETFs live since mid-year, raking in CAD $150M+ AUM. Europe? 21Shares launched its physical XRP ETP back in 2024, now eyeing Wall Street.

Timeline’s tight. Initial S-1 hit in early November 2024. Then 8-A filings in late November 2025 triggered the 20-day clock. Purpose ETFs and others are in the queue too, but 21Shares leads the pack. As of today, December 9, XRP sits at $2.41, up 4.2% in 24 hours on this news (CoinGecko data).

Context matters. Post-election clarity under Trump 2.0 has crypto ETFs exploding—BTC hit $108K, ETH at $4.2K. XRP lagged with $33B market cap vs. SOL’s $250B, but ETF chatter’s bridging that gap. We’ve tracked whale accumulation since Q3: 500M+ XRP off exchanges in past month alone (Santiment).

The Numbers

Let’s break it down cold.

Source: CoinGecko, Coingape reports as of Dec 9, 2025. Non-US XRP ETPs already pulled $666M since November launches—21Shares’ own TOXR in Europe hit $100M AUM week one. US version? Analysts eye $500M-$1B first month if approved, rivaling early SOL ETF flows.

On-chain: Exchange outflows spiked 29% last week ahead of this filing. Whale wallets (1K+ XRP) added 120M tokens since Thanksgiving. Open interest on Binance XRP perps? Up 15% to $450M.

Who’s Affected

XRP holders first. Regulated exposure means BlackRock, Fidelity types can pile in without self-custody headaches. Retail on Robinhood, Webull gets easy access too. Ripple? Massive win—legitimizes XRP for payments, ODL. They’ve been stacking ETF filings like Grayscale’s mini trusts.

Competitors: Bitwise, Canary, WisdomTree in the XRP race. 21Shares’ fee cut undercuts ’em—Purpose at 0.39%, Grayscale higher. Exchanges like Coinbase (custodian plays) and Cboe win big on listings. Bears? Short-term XRP sellers facing squeeze if inflows hit.

Institutional angle: Pension funds, hedge funds sidelined on XRP now jump. We’ve seen $2B+ BTC ETF inflows weekly; XRP could siphon 10-20% of that altcoin hunger.

What Comes Next

SEC clock ticks. Effectiveness could drop any day—mid-December latest if no hitches. Form 19b-4 already effective for Cboe listing. Watch for:

• SEC nod by Dec 15: Trading starts week of Dec 22.
• Delay? Pushes to Q1 2026, but post-Trump, unlikely.
• Seed capital: 21Shares seeded with 500K XRP (~$1.2M).

Price catalysts: Approval pumps 20-50% historically (SOL ETF +32%). Key levels—support $2.20, resistance $2.65. RSI at 68, not overheated yet. Whale moves on XRP Ledger next 48 hours tell the tale.

Broader: If TOXR launches, expect copycats. Dogecoin ETF? 21Shares amended that S-1 last week too, fee at 0.50%. Meme-to-utility shift accelerates.

The Bigger Picture

ETFs are crypto’s golden ticket. BTC/ETH approvals 2024 unlocked trillions in sidelined capital. XRP’s turn cements it as payments kingpin, not just ‘bank coin.’ But SEC ghost? Gensler’s out, but Paul Atkins incoming—pro-crypto, but XRP’s history lingers.

Bulls scream $5-10 EOY on ETF + RLUSD stablecoin launch. Bears counter: XRP Ledger TVL still peanuts at $1.2B vs. Solana’s $10B. Velocity high, but adoption slow outside remittances.

We’ve covered Ripple since 2017 cross-border push. This filing? Closest to reality yet. Global XRP ETFs already proving demand—US seals it. Competition heats: SOL ETFs at $5B AUM monthly. XRP needs $2B+ flows to flip narrative.

Sentiment split on X. ‘Probably nothing’ crowd vs. ‘TO THE MOON’ maxis. On-chain doesn’t lie—accumulation’s real. But post-pump dumps? Seen it 2017, 2021.

Bottom Line

Bullish setup, no cap. 21Shares’ fee slash and clean filing scream imminent launch. XRP’s primed for $3+ on approval, but watch SEC silence—could drag. We’ve flagged ETF alpha since summer; this confirms it. Accumulate dips, but size smart—alts bleed fast.

(Check SEC filing here. Price charts via CoinGecko. Inflows from Coingape.)

Frequently Asked Questions

What is 21Shares’ amended S-1 for XRP ETF?

Amendment No. 5 filed December 8, 2025, revises the 21Shares Core XRP Trust S-1. It cuts fees to 0.21%, confirms Cboe BZX listing as TOXR, and finalizes custody with Anchorage/BitGo. Sets stage for SEC effectiveness and launch.

When will the 21Shares XRP ETF launch?

Launch expected mid-to-late December 2025 if SEC declares effective soon. 19b-4 already in; trading on Cboe BZX post-approval. Delays possible but unlikely under current regs.

What is the fee for 21Shares XRP ETF (TOXR)?

Sponsor fee drops to 0.21% after initial waiver, making it competitive. Total expense ratio competitive with SOL ETFs at 0.25%. Waiver covers first six months.

How has XRP price reacted to the filing?

XRP jumped 4.2% to $2.41 in 24 hours post-filing. Volume spiked 28% to $4.2B. Global ETF inflows hint at more upside on US approval.

Will the XRP ETF get SEC approval?

High odds post-Ripple ruling and pro-crypto shift. Filing removes hurdles; analysts peg 90%+ chance by year-end. But SEC could nitpick custody or markets.